SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 409 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,832,565 | +27.0% | 56,365 | +19.9% | 0.03% | +30.0% |
| Q2 2023 | $5,381,867 | +85.8% | 46,995 | +123.7% | 0.02% | +66.7% |
| Q1 2023 | $2,896,084 | +2.9% | 21,012 | -3.3% | 0.01% | 0.0% |
| Q4 2022 | $2,814,866 | +20.7% | 21,723 | +3.0% | 0.01% | +9.1% |
| Q3 2022 | $2,332,000 | +40.7% | 21,093 | -4.6% | 0.01% | +57.1% |
| Q2 2022 | $1,658,000 | -30.6% | 22,113 | -27.7% | 0.01% | -12.5% |
| Q1 2022 | $2,388,000 | -28.1% | 30,571 | -17.1% | 0.01% | -20.0% |
| Q4 2021 | $3,322,000 | -7.4% | 36,896 | -4.9% | 0.01% | -16.7% |
| Q3 2021 | $3,588,000 | +34.2% | 38,799 | +12.8% | 0.01% | +33.3% |
| Q2 2021 | $2,674,000 | +9.0% | 34,398 | +4.5% | 0.01% | 0.0% |
| Q1 2021 | $2,453,000 | -71.0% | 32,910 | -33.6% | 0.01% | -71.0% |
| Q4 2020 | $8,450,000 | +26.5% | 49,564 | +4.2% | 0.03% | +10.7% |
| Q3 2020 | $6,680,000 | -7.1% | 47,569 | +6.1% | 0.03% | -17.6% |
| Q2 2020 | $7,187,000 | +88.5% | 44,823 | +15.0% | 0.03% | +41.7% |
| Q1 2020 | $3,812,000 | +3.3% | 38,969 | +36.3% | 0.02% | +26.3% |
| Q4 2019 | $3,689,000 | +82.8% | 28,586 | +6.7% | 0.02% | +58.3% |
| Q3 2019 | $2,018,000 | -47.7% | 26,796 | +5.6% | 0.01% | -45.5% |
| Q2 2019 | $3,855,000 | +68.9% | 25,373 | +32.5% | 0.02% | +57.1% |
| Q1 2019 | $2,282,000 | -11.0% | 19,143 | -18.5% | 0.01% | -26.3% |
| Q4 2018 | $2,563,000 | -46.3% | 23,490 | -20.6% | 0.02% | -34.5% |
| Q3 2018 | $4,777,000 | +20.4% | 29,575 | -1.5% | 0.03% | +7.4% |
| Q2 2018 | $3,968,000 | +59.0% | 30,020 | -10.9% | 0.03% | +50.0% |
| Q1 2018 | $2,495,000 | -0.6% | 33,675 | -25.3% | 0.02% | +5.9% |
| Q4 2017 | $2,510,000 | +25.1% | 45,110 | +2.0% | 0.02% | +13.3% |
| Q3 2017 | $2,006,000 | +249.5% | 44,235 | +159.8% | 0.02% | +275.0% |
| Q2 2017 | $574,000 | +328.4% | 17,025 | +68.6% | 0.00% | – |
| Q1 2015 | $134,000 | -15.7% | 10,100 | -8.2% | 0.00% | – |
| Q4 2014 | $159,000 | -76.4% | 11,000 | -23.0% | 0.00% | -100.0% |
| Q3 2013 | $674,000 | +178.5% | 14,282 | +124.0% | 0.00% | – |
| Q2 2013 | $242,000 | – | 6,375 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
| Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
| Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
| Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
| Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
| Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
| ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
| Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
| Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
| GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |